Treatment of patients, who have Mucopolysaccharidosis Type I, receiving pentosanpolysulfate subcutaneous injections weekly Treatment of patients, who have Mucopolysaccharidosis Type I, receiving pentosanpolysulfatesubcutan ...
An open label, randomized study to investigate the safety of weekly pentosanpolysulfate injections in adult patients with Mucopolysaccharidosis Type I receiving enzyme replacement therapy. An open label, randomized study to investigate the safety of weekly pentosanpolysulfateinjections i ...
Mucopolysaccharidosis type I (alpha-L-Iduronidase deficiency) MedDRA version: 17.0;Level: LLT;Classification code 10056888;Term: Mucopolysaccharidosis IS;System Organ Class: 100000004850 MedDRA version: 17.0;Classification code 10056887;Term: Mucopolysaccharidosis IH/S;Classification code 10028094;Term: Mucopolysaccharidosis IH;System Organ Class: 100000004850;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18] Mucopolysaccharidosis type I (alpha-L-Iduronidase deficiency) MedDRA version: 17.0;Level: LLT;Classi ...
Trade Name: Pentosan Polysulfat SP 54® injection solution Product Name: Pentosan Polysulphate SP54® INN or Proposed INN: PENTOSANPOLYSULFATESODIUM Other descriptive name: Pentosan Polysulphate SP54 Trade Name: PentosanPolysulfat SP 54® injection solution Product Name: PentosanPolysulphate SP54® INN ...